Foosung
Foosung Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of chemical products for automotive, iron and steel, semiconductor, construction, and environmental industries in South Korea. The company offers specialty gases, such as hexafluorobutadiene, tungsten hexafluoride, difluoromethane, and trifluoromethane; secondary battery materials, including lithium hexafluorop… Read more
Foosung (093370) - Total Liabilities
Latest total liabilities as of September 2025: ₩499.67 Billion KRW
Based on the latest financial reports, Foosung (093370) has total liabilities worth ₩499.67 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Foosung - Total Liabilities Trend (2006–2024)
This chart illustrates how Foosung's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Foosung Competitors by Total Liabilities
The table below lists competitors of Foosung ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Flag Chemical Industry Co Ltd
SHE:300575
|
China | CN¥2.65 Billion |
|
Atlanticus Holdings Corporation
NASDAQ:ATLC
|
USA | $6.45 Billion |
|
Great Taipei Gas Corp
TW:9908
|
Taiwan | NT$5.64 Billion |
|
Nova Minerals Limited
NASDAQ:NVA
|
USA | $2.69 Million |
|
Foresee Pharmaceuticals Co Ltd
TWO:6576
|
Taiwan | NT$593.99 Million |
|
Jiangsu Boiln Plastics Co. Ltd.
SHE:301003
|
China | CN¥59.26 Million |
|
TaiMed Biologics
TWO:4147
|
Taiwan | NT$896.74 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down Foosung's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Foosung's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Foosung (2006–2024)
The table below shows the annual total liabilities of Foosung from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩493.53 Billion | -5.44% |
| 2023-12-31 | ₩521.91 Billion | +0.67% |
| 2022-12-31 | ₩518.46 Billion | +55.75% |
| 2021-12-31 | ₩332.88 Billion | +12.86% |
| 2020-12-31 | ₩294.94 Billion | +3.14% |
| 2019-12-31 | ₩285.96 Billion | +45.91% |
| 2018-12-31 | ₩195.98 Billion | +82.81% |
| 2017-12-31 | ₩107.20 Billion | -29.33% |
| 2016-12-31 | ₩151.70 Billion | -7.15% |
| 2015-12-31 | ₩163.39 Billion | -4.23% |
| 2014-12-31 | ₩170.61 Billion | +7.88% |
| 2013-12-31 | ₩158.15 Billion | -1.98% |
| 2012-12-31 | ₩161.34 Billion | -7.66% |
| 2011-12-31 | ₩174.71 Billion | +34.47% |
| 2010-12-31 | ₩129.93 Billion | +31.34% |
| 2009-12-31 | ₩98.92 Billion | -3.41% |
| 2008-12-31 | ₩102.41 Billion | -15.74% |
| 2007-12-31 | ₩121.55 Billion | +111.59% |
| 2006-12-31 | ₩57.45 Billion | -- |